Recruiting Cardiomyopathy Studies in Birmingham
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy....
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on my...
About Cardiomyopathy Clinical Trials in Birmingham
Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated, hypertrophic, and restrictive cardiomyopathy. Treatment depends on the type and may include medications, devices, or heart transplant.
There are currently 2 cardiomyopathy clinical trials recruiting participants in Birmingham, ALABAMA. These studies are seeking a combined 750 participants. Research is being sponsored by Cytokinetics, Dennis M. McNamara, MD, MS. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cardiomyopathy Clinical Trials in Birmingham — FAQ
Are there cardiomyopathy clinical trials in Birmingham?
Yes, there are 2 cardiomyopathy clinical trials currently recruiting in Birmingham, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What cardiomyopathy treatments are being tested?
The 2 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for cardiomyopathy.
Data updated March 2, 2026 from ClinicalTrials.gov